Establishment and characterization of the growth and pulmonary metastasis of a highly lung metastasizing cell line from canine osteosarcoma in nude mice - PubMed (original) (raw)
Establishment and characterization of the growth and pulmonary metastasis of a highly lung metastasizing cell line from canine osteosarcoma in nude mice
E F Barroga et al. J Vet Med Sci. 1999 Apr.
Free article
Abstract
Highly lung metastasizing model of canine osteosarcoma in nude mice was established from five subcutaneous implantation cycles of lung tumor deposits. The selection of cells with increased metastatic properties from the parent POS canine osteosarcoma cell line recovered medium sized and polygonal Highly Metastasizing POS cells (HMPOS). The doubling time of HMPOS and POS in culture averaged 30 +/- 1.2 hr and 32 +/- 1.3 hr respectively, and their cell growth patterns in vitro were comparable to their in vivo growth patterns. HMPOS cells produced more tumor deposits (> 20 nodules, > 1 -mm in diameter) of various sizes with replacement of lung tissues at 12 weeks after implantation. POS cells produced fewer and smaller lung deposits (< 10 nodules, 1-mm in diameter). Tumor size and number of metastatic tumor deposits showed a regular association. HMPOS cells developed an osteoblastic type of cellular differentiation subcutaneously and in the lungs. HMPOS micrometastasis along the alveolar walls and blood vessels at 4 weeks averaged 6-7 small tumor locus. Each micrometastatic locus contained an average of 5-7 tumor cells, and developed a pleomorphic osteoblastic type of cellular differentiation. An average of 4 macrometastatic nodules could be seen at 6 weeks, composed of an average of 23 tumor cells, 10 nodules at 8 weeks, 12 nodules at 10 weeks and 20 nodules at 12 weeks. These model provides an opportunity for the evaluation of new treatments against canine lung metastatic osteosarcoma in a nude mice model.
Similar articles
- Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice.
Jaroensong T, Endo Y, Lee SJ, Kamida A, Mochizuki M, Nishimura R, Sasaki N, Nakagawa T. Jaroensong T, et al. Vet Comp Oncol. 2012 Dec;10(4):274-82. doi: 10.1111/j.1476-5829.2011.00294.x. Epub 2011 Sep 9. Vet Comp Oncol. 2012. PMID: 22236104 - Effect of all-trans and 9-cis retinoic acid on growth and metastasis of xenotransplanted canine osteosarcoma cells in athymic mice.
Hong SH, Kadosawa T, Mochizuki M, Matsunaga S, Nishimura R, Sasaki N. Hong SH, et al. Am J Vet Res. 2000 Oct;61(10):1241-4. doi: 10.2460/ajvr.2000.61.1241. Am J Vet Res. 2000. PMID: 11039554 - Establishment of human osteosarcoma cell lines with high metastatic potential to lungs and their utilities for therapeutic studies on metastatic osteosarcoma.
Kimura K, Nakano T, Park YB, Tani M, Tsuda H, Beppu Y, Moriya H, Yokota J. Kimura K, et al. Clin Exp Metastasis. 2002;19(6):477-85. doi: 10.1023/a:1020395816633. Clin Exp Metastasis. 2002. PMID: 12405284 - Cloning of canine osteosarcoma cells.
Nozaki K, Okuyama K, Kadosawa T, Nakayama H, Goto N, Sasaki N, Takeuchi A. Nozaki K, et al. J Vet Med Sci. 1995 Feb;57(1):23-8. doi: 10.1292/jvms.57.23. J Vet Med Sci. 1995. PMID: 7756419
Cited by
- Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers.
Takeuchi H, Konnai S, Maekawa N, Minato E, Ichikawa Y, Kobayashi A, Okagawa T, Murata S, Ohashi K. Takeuchi H, et al. Front Vet Sci. 2020 Jun 11;7:330. doi: 10.3389/fvets.2020.00330. eCollection 2020. Front Vet Sci. 2020. PMID: 32596272 Free PMC article. - Biological properties and gene expression associated with metastatic potential of human osteosarcoma.
Nakano T, Tani M, Ishibashi Y, Kimura K, Park YB, Imaizumi N, Tsuda H, Aoyagi K, Sasaki H, Ohwada S, Yokota J. Nakano T, et al. Clin Exp Metastasis. 2003;20(7):665-74. doi: 10.1023/a:1027355610603. Clin Exp Metastasis. 2003. PMID: 14669798 - Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapy.
Maekawa N, Konnai S, Asano Y, Sajiki Y, Deguchi T, Okagawa T, Watari K, Takeuchi H, Takagi S, Hosoya K, Kim S, Ohta H, Kato Y, Suzuki Y, Murata S, Ohashi K. Maekawa N, et al. Sci Rep. 2022 Jun 3;12(1):9265. doi: 10.1038/s41598-022-13484-8. Sci Rep. 2022. PMID: 35665759 Free PMC article. - Hyperbilirubinemia's protective effect against cisplatin nephrotoxicity in the Gunn rat.
Barabas K, Milner R, Farese J, Baylis C, Croker B, Archer L, Adin C. Barabas K, et al. Anticancer Drugs. 2008 Jun;19(5):495-502. doi: 10.1097/CAD.0b013e3282fdc391. Anticancer Drugs. 2008. PMID: 18418216 Free PMC article. - Osteocytes serve as a progenitor cell of osteosarcoma.
Sottnik JL, Campbell B, Mehra R, Behbahani-Nejad O, Hall CL, Keller ET. Sottnik JL, et al. J Cell Biochem. 2014 Aug;115(8):1420-9. doi: 10.1002/jcb.24793. J Cell Biochem. 2014. PMID: 24700678 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials